MCK

McKesson Corporation · NYSE · Healthcare · USD · 10-K for 2026, filed 2026-05-08

Figures on this page computed 2026-11-08 12:33 UTC

Last close

1,069.44USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2026, filed 2026-05-08

27.5xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2026
Accession
0000927653-26-000069
Reported in
USD
- computed
- 10-K for 2026, filed 2026-05-08
The filing itself
192.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2026
Accession
0000927653-26-000069
Reported in
USD
- 10-K for 2026, filed 2026-05-08
- 10-K for 2026, filed 2026-05-08
- 10-K for 2026, filed 2026-05-08
- 10-Q for 2026, filed 2026-08-05
- 10-K for 2026, filed 2026-05-08
- 10-Q for 2026, filed 2026-08-05
The filing itself
1.2%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2026
Accession
0000927653-26-000069
Reported in
USD
- 10-K for 2026, filed 2026-05-08
- 10-K for 2026, filed 2026-05-08
The filing itself
1.4%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2026
Accession
0000927653-26-000069
Reported in
USD
- 10-K for 2026, filed 2026-05-08
- 10-K for 2026, filed 2026-05-08
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2026
Accession
0000927653-26-000069
Reported in
USD
- 10-K for 2026, filed 2026-05-08
- 10-Q for 2026, filed 2026-08-05
The filing itself
0.3%Dividend yield
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
- computed
- computed
- computed
- computed
- Computed from the filing for 2026, filed 2026-05-08

Margins is the furthest below its sector's middle: 0.36 against 0.36 on the market's range.

All from 100

lens 2 of 9

Sales

203

2017-03-31 to 2026-03-31100 at the start203

Sales: 100.00 on 2017-03-31 to 203.21 on 2026-03-31, up 103%.

Profit

93.9

2017-03-31 to 2026-03-31100 at the start93.9

Profit: 100.00 on 2017-03-31 to 93.93 on 2026-03-31, down 6%.

Shares in issue

55.7

2017-03-31 to 2026-03-31100 at the start55.7

Shares in issue: 100.00 on 2017-03-31 to 55.65 on 2026-03-31, down 44%.

Sales is at 203, Profit is at 94, Shares in issue is at 56, against 100 in 2017.

Every figure in this lens

Except where said otherwise: 10-K for 2026, filed 2026-05-08

Sales, where the first year is 100203
Source
filed
Statement
income
Fiscal year
2026
Accession
0000927653-26-000069
Reported in
USD
The filing itself
Profit, where the first year is 10094
Source
filed
Statement
income
Fiscal year
2026
Accession
0000927653-26-000069
Reported in
USD
The filing itself
Shares in issue, where the first year is 10056
Source
filed
Statement
income
Fiscal year
2026
Accession
0000927653-26-000069
Reported in
USD
The filing itself